Kaya Holdings, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 16, 2021 at 03:50 pm
Share
Kaya Holdings, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 239,198 compared to USD 263,862 a year ago. Operating loss was USD 284,299 compared to USD 258,241 a year ago. Net income was USD 9.176 million compared to net loss of USD 1.424 million a year ago. Basic earnings per share from continuing operations was USD 0.61 compared to basic loss per share from continuing operations of USD 0.01 a year ago. For the half year, sales was USD 476,216 compared to USD 499,173 a year ago. Operating loss was USD 581,771 compared to USD 588,361 a year ago. Net income was USD 3.656 million compared to net loss of USD 2.082 million a year ago. Basic earnings per share from continuing operations was USD 0.25 compared to basic loss per share from continuing operations of USD 0.01 a year ago. Diluted earnings per share from continuing operations was USD 0.05 compared to diluted loss per share from continuing operations of USD 0.01 a year ago.
Kaya Holdings, Inc. is a holding company. The Company is focused on wellness and mental health through operations in psychedelic treatment clinics, medical and recreational cannabis, and cannabidiol (CBD) products. The Company produces, distributes, and/or sells a full range of cannabis products including flowers, oils, vape cartridges and cannabis infused confections, baked goods and beverages through a fully integrated group of subsidiaries and companies supporting highly distinctive brands. It operates through four subsidiaries, which include Marijuana Holdings Americas, Inc. (MJAI), Kaya Brand International, Inc. (KBI)., and Fifth Dimension Therapeutics, Inc. (FDT). MJAI maintains ownership of the Companyâs Oregon-based cannabis operations. FDT provides psychedelic mind care treatments to veterans suffering from PTSD, addicts seeking to break addiction, individuals with eating disorders, and others with an array of treatment resistant mental health disorders.